Switch to:
Also traded in: Argentina, Brazil, Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.41
MDT's Cash-to-Debt is ranked lower than
75% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. MDT: 0.41 )
Ranked among companies with meaningful Cash-to-Debt only.
MDT' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.15  Med: 0.82 Max: No Debt
Current: 0.41
0.15
No Debt
Equity-to-Asset 0.56
MDT's Equity-to-Asset is ranked lower than
67% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. MDT: 0.56 )
Ranked among companies with meaningful Equity-to-Asset only.
MDT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.37  Med: 0.63 Max: 0.82
Current: 0.56
0.37
0.82
Debt-to-Equity 0.51
MDT's Debt-to-Equity is ranked lower than
71% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 0.30 vs. MDT: 0.51 )
Ranked among companies with meaningful Debt-to-Equity only.
MDT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02  Med: 0.34 Max: 1.42
Current: 0.51
0.02
1.42
Debt-to-EBITDA 2.80
MDT's Debt-to-EBITDA is ranked lower than
64% of the 158 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. MDT: 2.80 )
Ranked among companies with meaningful Debt-to-EBITDA only.
MDT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.85  Med: 2.2 Max: 6.61
Current: 2.8
1.85
6.61
Interest Coverage 6.04
MDT's Interest Coverage is ranked lower than
82% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 66.37 vs. MDT: 6.04 )
Ranked among companies with meaningful Interest Coverage only.
MDT' s Interest Coverage Range Over the Past 10 Years
Min: 4.3  Med: 9.63 Max: 12.85
Current: 6.04
4.3
12.85
Piotroski F-Score: 8
Altman Z-Score: 3.10
Beneish M-Score: -2.64
WACC vs ROIC
4.03%
4.25%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 21.26
MDT's Operating Margin % is ranked higher than
88% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. MDT: 21.26 )
Ranked among companies with meaningful Operating Margin % only.
MDT' s Operating Margin % Range Over the Past 10 Years
Min: 20.67  Med: 25.72 Max: 29.47
Current: 21.26
20.67
29.47
Net Margin % 7.44
MDT's Net Margin % is ranked higher than
74% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. MDT: 7.44 )
Ranked among companies with meaningful Net Margin % only.
MDT' s Net Margin % Range Over the Past 10 Years
Min: 7.44  Med: 16.1 Max: 22.35
Current: 7.44
7.44
22.35
ROE % 4.48
MDT's ROE % is ranked higher than
59% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. MDT: 4.48 )
Ranked among companies with meaningful ROE % only.
MDT' s ROE % Range Over the Past 10 Years
Min: 4.48  Med: 16.42 Max: 22.29
Current: 4.48
4.48
22.29
ROA % 2.46
MDT's ROA % is ranked higher than
61% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -0.26 vs. MDT: 2.46 )
Ranked among companies with meaningful ROA % only.
MDT' s ROA % Range Over the Past 10 Years
Min: 2.46  Med: 8.73 Max: 11.99
Current: 2.46
2.46
11.99
ROC (Joel Greenblatt) % 73.27
MDT's ROC (Joel Greenblatt) % is ranked higher than
91% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 3.87 vs. MDT: 73.27 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MDT' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 51.55  Med: 70.37 Max: 79.72
Current: 73.27
51.55
79.72
3-Year Revenue Growth Rate 6.20
MDT's 3-Year Revenue Growth Rate is ranked higher than
63% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. MDT: 6.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MDT' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.2  Med: 13.9 Max: 18.6
Current: 6.2
4.2
18.6
3-Year EBITDA Growth Rate 12.00
MDT's 3-Year EBITDA Growth Rate is ranked higher than
53% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. MDT: 12.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MDT' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -3.7  Med: 16.5 Max: 26.5
Current: 12
-3.7
26.5
3-Year EPS without NRI Growth Rate -2.00
MDT's 3-Year EPS without NRI Growth Rate is ranked lower than
61% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 7.80 vs. MDT: -2.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MDT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -9.7  Med: 15.6 Max: 27.1
Current: -2
-9.7
27.1
GuruFocus has detected 7 Warning Signs with Medtronic PLC MDT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MDT's 30-Y Financials

Financials (Next Earnings Date: 2019-02-19)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2018

MDT Guru Trades in Q1 2018

Ken Fisher 216,956 sh (+32.13%)
T Rowe Price Equity Income Fund 3,320,000 sh (+3.75%)
Dodge & Cox 18,721,632 sh (+2.39%)
Joel Greenblatt 427,957 sh (+109.50%)
HOTCHKIS & WILEY 3,862,825 sh (+55.70%)
Jeremy Grantham 4,446,710 sh (+8.96%)
Jeff Auxier 161,248 sh (+3.81%)
Mairs and Power 3,668,495 sh (+0.77%)
First Pacific Advisors 16,400 sh (+212.38%)
Diamond Hill Capital 4,227,340 sh (+3.97%)
Vanguard Health Care Fund 15,408,784 sh (unchged)
Bill Nygren 3,190,000 sh (unchged)
First Eagle Investment Sold Out
Jim Simons Sold Out
Ray Dalio Sold Out
Signature Select Canadian Fund Sold Out
Robert Olstein 116,000 sh (-0.85%)
John Buckingham 25,086 sh (-0.25%)
PRIMECAP Management 8,179,292 sh (-6.56%)
David Carlson 560,000 sh (-30.00%)
Steven Cohen 741,199 sh (-53.36%)
Paul Tudor Jones 22,290 sh (-48.56%)
Caxton Associates 13,692 sh (-18.39%)
Barrow, Hanley, Mewhinney & Strauss 15,240,620 sh (-2.92%)
Pioneer Investments 4,086,932 sh (-23.25%)
Mario Gabelli 23,332 sh (-20.41%)
» More
Q2 2018

MDT Guru Trades in Q2 2018

Eaton Vance Worldwide Health Sciences Fund 117,565 sh (New)
Ken Fisher 226,743 sh (+4.51%)
T Rowe Price Equity Income Fund 3,460,000 sh (+4.22%)
Dodge & Cox 18,738,182 sh (+0.09%)
Joel Greenblatt 651,133 sh (+52.15%)
John Buckingham 25,106 sh (+0.08%)
Steven Cohen 823,622 sh (+11.12%)
Pioneer Investments 5,458,335 sh (+33.56%)
Mario Gabelli 23,744 sh (+1.77%)
David Carlson 560,000 sh (unchged)
Bill Nygren 3,190,000 sh (unchged)
Caxton Associates Sold Out
Vanguard Health Care Fund 14,533,984 sh (-5.68%)
Robert Olstein 86,000 sh (-25.86%)
HOTCHKIS & WILEY 3,627,625 sh (-6.09%)
PRIMECAP Management 8,162,952 sh (-0.20%)
Jeremy Grantham 3,568,527 sh (-19.75%)
Paul Tudor Jones 3,507 sh (-84.27%)
Mairs and Power 3,464,399 sh (-5.56%)
First Pacific Advisors 8,950 sh (-45.43%)
Diamond Hill Capital 4,018,635 sh (-4.94%)
Barrow, Hanley, Mewhinney & Strauss 14,589,501 sh (-4.27%)
Jeff Auxier 159,098 sh (-1.33%)
» More
Q3 2018

MDT Guru Trades in Q3 2018

Jim Simons 1,740,190 sh (New)
Stanley Druckenmiller 372,500 sh (New)
Ron Baron 2,722 sh (New)
Ken Fisher 233,816 sh (+3.12%)
Pioneer Investments 7,772,613 sh (+42.40%)
Joel Greenblatt 663,551 sh (+1.91%)
Paul Tudor Jones 11,351 sh (+223.67%)
John Buckingham 25,181 sh (+0.30%)
Eaton Vance Worldwide Health Sciences Fund 117,565 sh (unchged)
First Pacific Advisors 8,950 sh (unchged)
Bill Nygren 3,190,000 sh (unchged)
T Rowe Price Equity Income Fund 3,385,000 sh (-2.17%)
Vanguard Health Care Fund 13,104,084 sh (-9.84%)
David Carlson 460,000 sh (-17.86%)
Mario Gabelli 23,241 sh (-2.12%)
Robert Olstein 70,920 sh (-17.53%)
Barrow, Hanley, Mewhinney & Strauss 12,332,151 sh (-15.47%)
PRIMECAP Management 7,480,995 sh (-8.35%)
Diamond Hill Capital 3,886,612 sh (-3.29%)
Jeremy Grantham 3,480,300 sh (-2.47%)
Mairs and Power 3,237,193 sh (-6.56%)
HOTCHKIS & WILEY 3,183,899 sh (-12.23%)
Steven Cohen 46,400 sh (-94.37%)
Jeff Auxier 157,198 sh (-1.19%)